+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06026592

Studying Kidney-Origin Plasma DNA to Monitor Kidney Transplant Patients

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-09-24

30

Participants Needed

1

Research Sites

1 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating a new way to monitor kidney transplant rejection and dysfunction by measuring specific epigenetic markers in donor-derived cell-free DNA found in the blood. This approach aims to improve upon current methods, which rely on non-specific markers like serum creatinine and invasive kidney biopsies. The study focuses on distinguishing kidney DNA signals from the patients original kidney versus the transplanted kidney, especially in patients with chronic kidney disease undergoing transplantation. The study involves collecting blood samples from patients before and after kidney transplantation to measure renal-specific cell-free DNA using a patented multiplex digital-PCR assay. Researchers will also analyze graft perfusion fluid to validate these markers and study tissue damage during organ transport. This observational study does not involve treatment but focuses on evaluating the evolution and characteristics of kidney-derived DNA markers. Participants will provide blood samples at specific times about 6 hours before transplantation and 12 to 24 hours after surgery, with additional assessments 7 days post-transplant. The study measures include the amount of renal circulating cell-free DNA and the variability of these markers between individuals, as well as their association with graft function recovery. The study also monitors the presence of epigenetic signatures related to acute kidney injury and tracks graft performance over time.

CONDITIONS

Brief Title

Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients

Research Team

S

Sarah Dr DROUIN, MD-PhD

G

Geoffroy Dr POULET, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here